Magnetic Resonance Spectroscopy for Identification of Isocitrate Dehydrogenase Mutation in Gliomas

World Neurosurg. 2020 Feb:134:193-195. doi: 10.1016/j.wneu.2019.10.118. Epub 2019 Nov 11.

Authors

Andrea M Alexandre¹, Chiara Ciardi²

Affiliations

¹ UOC Radiology and Neuroradiology, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, A. Gemelli University Hospital Foundation, IRCCS, Rome, Italy. Electronic address: andrea.alexandre@libero.it.
² UOC Radiology and Neuroradiology, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, A. Gemelli University Hospital Foundation, IRCCS, Rome, Italy.

PMID: 31669686
DOI: 10.1016/j.wneu.2019.10.118

No abstract available

Keywords: 2-Hydroxyglutarate; 2HG; Glioma; MRS; Magnetic resonance spectroscopy; Neuroimaging.

Publication types

Comment

MeSH terms

Glioma*
Humans
Isocitrate Dehydrogenase / genetics*
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Mutation

Substances

Isocitrate Dehydrogenase